David Gius
Director, University of Cincinnati Cancer Center · University of Cincinnati Medical Center Inc.
Credentials: · · · · ·
History
PresentUniversity of Cincinnati Cancer Center · University of Cincinnati Medical Center Inc.
- 1993–1997
Radiation Oncology
- 1992–1993
Preliminary or Transitional Year
Research
Molecular Cell · 2010 · Last of 13 authors · Corresponding · 756 citations
Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA
Nature · 2008 · 668 citations
Cancer Cell · 2010 · Last of 18 authors · Corresponding · 667 citations
- JP
8 papers · 6 as a resident
6 papers
6 papers · 5 as a resident
6 papers · 1 as a resident
5 papers · 3 as a resident
4 papers · 2 as a resident
4 papers · 3 as a resident
- CW
4 papers
Grants
- 2021–2027
National Cancer Institute · R01
Contact PI · $2M · University of Cincinnati
- 2021–2026
MnSOD-K68-Ac Reprograms a Lineage Plasticity Switch / Stemness in ER+ Breast Malignancies
National Cancer Institute · R01
Contact PI · $2.1M · University of Cincinnati
- 2017–2024
Dys-Regulation of the MnSOD-Ac-ROS-HIF2a Axis Promotes IR / Cisplatin Resistance Phenotype
National Cancer Institute · R01
Contact PI · $2M · University of Texas Hlth Science Center
- 2010–2020
Loss of Mitochondrial Sirt3, Decreased MnSOD Activity, and IR Induced Genomic Instability
National Cancer Institute · R01
Contact PI · $3.2M · Northwestern University